Antitumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma

Suzuki, RikioHidehsima, TeruMimura, NaoyaMinami, JiroOhguchi, HirotoKikuchi, ShoheiYoshida, YasuhiroGorgun, GulluCirstea, DianaCottini, FrancescaJakubikova, JanaTai, Yu-TzuChauhan, DharminderRichardson, PaulMunshi, NikhilUtsugi, TeruhiroAnderson, Kenneth2015-09-012014Suzuki, R., T. Hidehsima, N. Mimura, J. Minami, H. Ohguchi, S. Kikuchi, Y. Yoshida, et al. 2014. “Antitumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma.” Leukemia 29 (2): 510-514. doi:10.1038/leu.2014.300. http://dx.doi.org/10.1038/leu.2014.300.0887-6924http://nrs.harvard.edu/urn-3:HUL.InstRepos:21462192en-USAntitumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myelomaJournal Article2015-09-0110.1038/leu.2014.300